Literature DB >> 26734560

Bisphosphonate-related osteonecrosis of the jaw in a patient with osteoporosis following treatment of testicular cancer: a case report.

Do-Sup Kim1, Jung-Ho Kim1, Joo-Young Ohe1, Jung-Woo Lee1, Byung-Jun Choi1, Baek-Soo Lee1, Yong-Dae Kwon1.   

Abstract

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) occurs mainly in female patients. In males the occurrence rate is low, which seems to be related to the low incidence of osteoporosis in men. Unfortunately, BRONJ tends to be ignored in general dental clinics in male patients with a history of osteoporosis treatment. BRONJ occurred in a male patient due to the clinician's lack of interest in the patient's history. In this case, the male patient was on bisphosphonate therapy because of a orchiectomy, and a dental treatment was performed without consideration of his medical history, resulting in BRONJ. We performed careful examinations and treatment with antibiotics and surgical operations. The postoperative healing was successful. In light of this particular case, we concluded that careful listening to the patient's history is very important.

Entities:  

Keywords:  Bisphosphonate-related osteonecrosis of the jaw; Orchiectomy; Osteoporosis

Year:  2015        PMID: 26734560      PMCID: PMC4699934          DOI: 10.5125/jkaoms.2015.41.6.327

Source DB:  PubMed          Journal:  J Korean Assoc Oral Maxillofac Surg        ISSN: 1225-1585


  9 in total

1.  Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.

Authors:  Alexandre T Assaf; Ralf Smeets; Björn Riecke; Eva Weise; Alexander Gröbe; Marco Blessmann; Tim Steiner; Johannes Wikner; Reinhard E Friedrich; Max Heiland; Frank Hoelzle; Frank Gerhards
Journal:  Anticancer Res       Date:  2013-09       Impact factor: 2.480

2.  Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris.

Authors:  P Maurer; T Sandulescu; M S Kriwalsky; A Rashad; S Hollstein; I Stricker; F Hölzle; M Kunkel
Journal:  Int J Oral Maxillofac Surg       Date:  2010-12-15       Impact factor: 2.789

3.  Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medication-related osteonecrosis of the jaw.

Authors:  Horatiu Rotaru; Min-Keun Kim; Seong-Gon Kim; Young-Wook Park
Journal:  J Oral Maxillofac Surg       Date:  2014-10-13       Impact factor: 1.895

Review 4.  Osteoporosis in men.

Authors:  Evelien Gielen; Dirk Vanderschueren; Filip Callewaert; Steven Boonen
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-04       Impact factor: 4.690

5.  Bisphosphonate-related osteonecrosis of the skull base.

Authors:  Aayesha M Khan; Raj Sindwani
Journal:  Laryngoscope       Date:  2009-03       Impact factor: 3.325

6.  Oral health risk factors for bisphosphonate-associated jaw osteonecrosis.

Authors:  Claudine Tsao; Ivan Darby; Peter R Ebeling; Katrina Walsh; Neil O'Brien-Simpson; Eric Reynolds; Gelsomina Borromeo
Journal:  J Oral Maxillofac Surg       Date:  2013-04-11       Impact factor: 1.895

7.  Buccal fat pad, an oral access source of human adipose stem cells with potential for osteochondral tissue engineering: an in vitro study.

Authors:  Elisabet Farré-Guasch; Carles Martí-Pagè; Federico Hernádez-Alfaro; Jenneke Klein-Nulend; Núria Casals
Journal:  Tissue Eng Part C Methods       Date:  2010-10       Impact factor: 3.056

8.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

Review 9.  Treatment of osteoporosis in men.

Authors:  J-M Kaufman; J-Y Reginster; S Boonen; M L Brandi; C Cooper; W Dere; J-P Devogelaer; A Diez-Perez; J A Kanis; E McCloskey; B Mitlak; E Orwoll; J D Ringe; G Weryha; R Rizzoli
Journal:  Bone       Date:  2012-11-28       Impact factor: 4.398

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.